Canvas access has been restored for our users, but the service reliability remains uncertain. Due to recent events, Canvas has had intermittent outages which are at the discretion of the vendor and may occur during a final exam. Faculty and staff may continue to use Canvas, but we strongly advise faculty and students to prepare a contingency plan for turning in assignments and final exams in the event Canvas access becomes unavailable again.
Instructure, the company that owns Canvas, has provided an FAQ about the incident, which may not answer all your questions. We will share more information if it becomes available.
ProfessorDirector of Innovation and Commercialization, Director of Entrepreneurship Education, SPARK/REACH Program, Director of the Center of Excellence Program for Model Informed Drug Development
BS Pharmacy, University of Pittsburgh, Pittsburgh, Pennsylvania (Magna Cum Laude)
Awards
Affiliations
Professor, University of Colorado, School of Medicine, Division of Kidney Diseases and Hypertension
Member, University of Colorado, Cancer Center
Member, Colorado Center for Personalized Medicine
Member, Center for Translational Pharmacokinetics and Pharmacogenomics
Member, Center for Drug Discovery
Member, Colorado Center for Nanomedicine and Nanosafety
Founder/Scientific Advisor, Katharos, Inc.
Research Interest
Kidney Disease Pharmacology
Publications and Presentations
Ibrahim ME, Chang C, Hu Y, Hogan SL, Mercke N, Gomez M, O'Bryant CL, Bowles DW, George B, Wen X, Buckley B, Aleksunes L, Joy MS. Pharmacokinetic determinants of cisplatin-induced subclinical kidney injury in oncology patients. Eur J Clin Pharmacol. 2018 Sep 15. [Epub ahead of print]. PMID: 30220072.
Chang C, Hu Y, Hogan SL, Mercke N, Gomez M, O’Bryant C, Bowles DW, George B, Wen X, Aleksunes LM, Joy MS. Pharmacogenomic variants may influence the urinary excretion of novel kidney injury biomarkers in patients receiving cisplatin. Int J Mol Sci 2017;Jun 22;18(7).
Skaggs School of Pharmacy and Pharmaceutical Sciences